
    
      In this 2-site clinical trial, intended to evaluate the safety and efficacy of repeated doses
      of ketamine for treatment resistant PTSD, Veterans and active duty military personnel who
      meet criteria for PTSD and the additional inclusion and exclusion criteria will be randomized
      to one of three treatment arms (placebo, low dose ketamine, high dose ketamine). Participants
      receive the study drug via intravenous infusion twice per week for 4-weeks.
    
  